Study of the Effect of Food Intake on the Bioavailability of XC221 100 mg Tablets

NCT05295121 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Valenta Pharm JSC